This is not the latest version of this item. The latest version can be found here.
Weight gain after in vitro fertilization: a potential consequence of controlled ovarian stimulation
Name
10815_2022_2444_ReferencePDF.pdf
Size
542.38 KB
Format
Adobe PDF
Checksum (MD5)
f7d81bc69dbc93a76fe563030b29c80e
Author(s)
Bajaj, Simar S.
Jain, Bhav
Stanford, Fatima C.
Date Issued
February 26, 2022
Publisher
Springer US
Citation
Bajaj, Simar S., Jain, Bhav and Stanford, Fatima C. 2022. "Weight gain after in vitro fertilization: a potential consequence of controlled ovarian stimulation."
Version
Author's final manuscript
Abstract
Abstract
In the USA, 42% of adult women were estimated to have obesity, and 13% of women of childbearing age similarly have impaired fecundity. Obesity is associated with infertility such that patients with obesity often seek out in vitro fertilization (IVF) services. Here, we report on the case of a woman with childhood-onset class II obesity who had been undergoing treatment with phentermine and topiramate prior to undergoing 3 cycles of IVF. With each cycle, the patient temporarily gained 13–15 lbs. during controlled ovarian stimulation (COS). Weight gain from COS may be clinically relevant and merits further study to optimize weight status across women’s reproductive life and to better assist women who gain weight secondary to IVF. Incorporating weight monitoring into IVF protocols may also help better characterize the scope of weight gain from COS.
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1007/s10815-022-02444-w
